Health Care Resource Utilization and Costs of Major Adverse Thrombotic Events in Patients with and without ESKD
- PMID: 40549448
- DOI: 10.34067/KID.0000000867
Health Care Resource Utilization and Costs of Major Adverse Thrombotic Events in Patients with and without ESKD
Keywords: ESKD; USRDS (United States Renal Data System); cardiovascular events; cohort studies; economic analysis; epidemiology and outcomes; hemodialysis; peritoneal dialysis; thrombosis.
References
-
- Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare population. J Am Soc Nephrol. 2013;24(9):1478–1483. doi: 10.1681/ASN.2012040392 - DOI
-
- Kent S, Schlackow I, Lozano-Kühne J, et al. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? BMC Nephrol. 2015;16:65. doi: 10.1186/s12882-015-0054-0 - DOI
-
- Wyld ML, Lee CM, Zhuo X, et al. Cost to government and society of chronic kidney disease stage 1-5: a national cohort study. Intern Med J. 2015;45(7):741–747. doi: 10.1111/imj.12797 - DOI
-
- Golestaneh L, Alvarez PJ, Reaven NL, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10 suppl):S163–S172. PMID: 28978205
-
- Nichols GA, Ustyugova A, Déruaz-Luyet A, O'Keeffe-Rosetti M, Brodovicz KG. Health care costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrol. 2020;31(7):1594–1601. doi: 10.1681/ASN.2019121308 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
